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Abstract
Background: Acupuncture is increasingly used as an additional treatment for patients with Parkinson’s disease (PD).
Methods: In this functional magnetic resonance imaging study, brain activation in response to acupuncture in a
group of 12 patients with PD was compared with a group of 12 healthy participants. Acupuncture was conducted
on a specific acupoint, the right GB 34 (Yanglingquan), which is a frequently used acupoint for motor function
treatment in the oriental medical field.
Results: Acupuncture stimulation on this acupoint activates the prefrontal cortex, precentral gyrus, and putamen in
patients with PD; areas that are known to be impaired in patients with PD. Compared with healthy participants,
patients with PD showed significantly higher brain activity in the prefrontal cortex and precentral gyrus, especially
visible in the left hemisphere.
Conclusions: The neuroimaging results of our study suggest that in future acupuncture research; the prefrontal
cortex as well as the precentral gyrus should be treated for symptoms of Parkinson’s disease and that GB 34 seems
to be a suitable acupoint. Moreover, acupuncture evoked different brain activations in patients with Parkinson’s
disease than in healthy participants in our study, stressing the importance of conducting acupuncture studies on
both healthy participants as well as patients within the same study, in order to detect acupuncture efficacy.
Trial registration: KCT0001122 at cris.nih.go.kr (registration date: 20140530)
Keywords: Functional magnetic resonance imaging, Parkinson’s, Healthy, Patient
Background
Acupuncture is an important modality of complemen-
tary medicine [1,2] and numerous researchers have stud-
ied its effects [3-6]. In acupuncture studies, functional
magnetic resonance imaging (fMRI) is the most com-
monly applied method of functional neuroimaging, be-
cause it can indirectly measure brain activity and functional
changes of the brain without harmful radiation and invasive
procedures [5,7-11].
To measure the effects of acupuncture with fMRI,
studies have been conducted on healthy participants
[12-15], indicating that each acupoint has its own spe-
cific effect, and on patients with diseases, showing that
acupuncture is able to improve the symptoms of patients
[16-18]. However, to our knowledge, there has so far
been no fMRI study that directly measures and com-
pares brain activity in response to acupuncture stimulat-
ing manipulation in healthy participants to those of
patients with Parkinson’s disease (PD). Because acupunc-
ture is being used to treat patients with PD [19], it is im-
portant to conduct an fMRI study on both patients with
PD and healthy participants, to better understand the ef-
fects of acupuncture on patients with PD, and possibly
look for evidence of its functional mechanism. Moreover,
compared to healthy participants, abnormal brain activa-
tion was reported in the patients with PD [20], therefore
it is important to investigate whether acupuncture
stimulation on GB 34 has an effect on brain areas that
are known to show dysfunction.
PD is one of the most common neurodegenerative dis-
orders. Its characteristic features include rest tremor,
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rigidity, and bradykinesia [21-23]. Complementary and
alternative therapy is being used more often as a com-
plementary treatment to Western medicine for patients
with PD [24-27]. As many as 40% of patients with PD
use some form of complementary medicine during the
course of their illness [28], and among these, acupunc-
ture is popular [1]. Acupuncture has been reported to
have a neuroprotective effect in PD animal models
[4,29-32]. In particular, the acupoint GB 34 was reported to
lead to significant improvements in patients with PD
[1,33,34] and significant neuroprotective effects in PD ani-
mal models [6,35,36].
Based on the literature, we hypothesize that acupunc-
ture stimulation on GB 34 has an effect on brain areas
that are known to show dysfunction due to nigral dopa-
mine depletion: the prefrontal cortex [37], precentral
gyrus [38], thalamus [39], globus pallidus [40], caudate
[41], and putamen [38]. Moreover, our second hypoth-
esis is that a significant difference in brain activity in pa-
tients with PD compared with healthy participants will
be found.
Methods
Ethics statement
This study has been approved by the Clinical Research
Information Service (CRiS). The approved number is
“KCT0001122” and the topic is titled “Development of
Acupuncture Treatment for patient with Parkinson’s dis-
ease”. Participants were given written information and
verbal explanation concerning the study.
Participants
Twenty-four volunteers participated following written
informed consent according to the institutional guide-
lines of IRB and in accordance with the Declaration of
Helsinki. 12 participants were idiopathic patients with
PD (mean age = 53.5 years (range: 38–72), 6 males),
whereas the other 12 volunteers were healthy partici-
pants, matched for age (mean age = 55.9, (range: 35–
71)) and gender (6 males). Patients with atypical parkin-
sonian disorder, other neurological or major medical
conditions (e.g. head injury, stroke) or current psychi-
atric problems were excluded from the study. All healthy
volunteers and patients with PD were familiar with acu-
puncture stimulation to control for the acupuncture ex-
perience in the study. PD participants were diagnosed
with clinically definite idiopathic PD by a neurologist
from the Kyung Hee Medical Hospital. All were studied
in the “off” condition; 12 hours after all anti-parkinsonian
drugs had been withheld. Four patients with PD showed
right-onset, 5 patients showed left-onset and 3 patients
showed bilateral-onset. All had Hoehn and Yahr stage [42]
1, 2, or 2.5. The mean Unified Parkinson’s Disease Rating
Scale (UPDRS) [43] motor score was 7.8 (SD = 3.9). All
patients with PD were right-handed as verified by the Ed-
inburg Handedness Inventory [44]; their mean score was
99.6% (SD = 1.4). The average duration of disease was 2.7
years. Healthy participants were without any neurological
or psychiatric history and were all right-handed as verified
by the Edinburgh Handedness Inventory [44]; their mean
score was 100% (SD = 0, Additional file 1: Table S1).
Acupuncture
An eastern medical doctor with more than 5 years of
clinical experience conducted acupuncture on the right
GB 34 (Yanglingquan) (Additional file 2: Figure S1), ac-
cording to the WHO Standard Acupuncture Point Loca-
tions and according to the STRICTA norms [45]. This
acupoint, which is on the fibular aspect of the leg, in the
depression anterior and distal to the head of the fibula,
was chosen because it is reported that it leads to signifi-
cant neuroprotective effects in PD animal models [6,46]
and significant improvements in patients with PD [34,47].
For verum acupuncture stimulation (ACUP), the needle
(0.25 × 40 mm, Dong Bang Acupuncture Inc. Seoul,
Korea) was manually inserted into the right GB 34 to a
depth of approximately 1.0 cm. During ACUP, there were
blocks in which the needle was “stimulated”, for which the
needle was not only inserted into the skin, but also rotated
bidirectionally at 1 Hz and there were blocks in which the
needle was “not stimulated”, for which the needle was
only inserted into the skin and then left in place. For sham
acupuncture stimulation (SHAM) [48], a blunt type nee-
dle was used [47]. In contrast to ACUP, the blunt type
needle was not inserted into the skin. With the exception
of this, the same paradigm as for ACUP was used.
Experimental design and procedure
The participants received general instructions of the ex-
periment, followed by more detailed instructions for the
specific task. First, participants signed the informed con-
sent form, according to institutional guidelines of the
Human Research Committee of Kyung Hee Medical
Hospital. Then, all participants completed the Edinburgh
Handedness Inventory [44], Hoen and Yahr stage [42],
and were reminded of the specific task instructions of
the fMRI experiment. They were instructed not to move
their bodies and heads [49]. A block design was used.
The scanning experiment started with the SHAM condi-
tion with 5 minutes durations. Then, anatomical refer-
ence images were obtained for more than 15 minutes,
followed by the ACUP condition with 5 minutes dura-
tions (Additional file 3: Figure S2). Following the ACUP
and SHAM scannings, participants rated the intensity of
the sensation they felt [48]. Finally, after the fMRI ex-
periment, participants conducted the UPDRS [43], the
Korean Mini-Mental State Examination [50] and the
Beck Depression Inventory [51].
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MRI data acquisition
A Philips 3.0 T MRI system (Philips, Netherlands) equipped
for echo planer imaging (EPI) was used for data acquisition.
For each participant, 270 contiguous EPI functional volumes
(time repetition [TR] = 2000 ms, time echo [TE] = 35 ms,
flip angle = 90°, slice thickness = 4.5, matrix = 96 × 128, field
of view [FOV] = 230 × 182 × 135 mm, acquisition voxel
size = 2.4 × 2.4 × 4.5 mm) were collected. During scan-
ning, participants remained in the supine position with
their heads immobilized by cushioned supports. They wore
ear plugs throughout the experiment to attenuate MRI gra-
dient noise. Moreover, they were instructed to rest with
their eyes closed and not to move. For spatial normalization
and localization, a high resolution T1-weighted anatomical
image was then acquired using a magnetization prepared
gradient echo sequence (time repetition [TR] = 9.9 ms, time
echo [TE] = 4.6 ms, flip angle = 90°, slice thickness = 1 mm,
matrix = 236 × 240, field of view [FOV] = 235 × 235 ×
196 mm, acquisition voxel size = 1 × 1 × 1 mm).
MRI data analysis
fMRI data were analyzed using SPM5. The first five
volumes of each participant’s dataset were discarded to
allow for T1 equilibration. The functional EPI-blood
oxygenation level dependant (BOLD) images were rea-
ligned, and the subject-mean functional MR images
were co-registered with the corresponding structure
MR images. These images were spatially normalized
and transformed into a common space, as defined by
the SPM Montreal Neurological Institute (MNI) T1 tem-
plate. The functional EPI-BOLD images were spatially
smoothed with a Gaussian kernel of 8 mm FWHM
(full-width half-maximum).
The fMRI data were then statistically analyzed using the
general linear model and statistical parametric mapping of
SPM5. At the first-level, single-subject fixed effect analyses
were conducted. A model with the experiment conditions
was tested in each participant’s data separately. For second-
level analysis, the generated contrast images for the main
effects were assessed by conducting a one-sample t-test.
The comparison between healthy participants and patients
with PD was assessed by conducting a two-sample t-test.
Significant differences were accepted at a threshold of cor-
rected cluster level P < 0.05 [52].
All local maxima are reported as Talairach coordinates.
In addition, the cluster size and the peak t value of areas
of significant increase are given. Relevant anatomical
landmarks and Brodmann areas were identified using
GingerALE (http://www.brainmap.org) and analyzed step
by step using Talairach Client (http://www.talairach.org).
The regions of interest (ROI) were fixed using Automated
Anatomical Labeling. The activated volume of ROI of
each region was measured using MRIcroN. The volume
comparison between ACUP and SHAM in each group
was assessed by conducting a paired-t test (SPSS Inc.,
Chicago, IL, USA).
Results
Psychophysical responses
The intensity of sensations measured by an average score
was reported on a scale from 0 (denoting no sensation) to
10 (denoting an unbearable sensation between patients with
PD and healthy participants during ACUP and SHAM).
The average stimulus intensities (mean ± SD) were approxi-
mately similar during ACUP of patients with PD (2 ± 2.4),
SHAM of patients with PD (1.3 ± 2.0), ACUP of healthy par-
ticipants (1.4 ± 2.1), and SHAM of healthy participants
(0.9 ± 1.9); no significant statistical differences were
found.
PD related brain activation induced by ACUP and SHAM
in healthy participants and patients with PD
In healthy participants, the right putamen, left and
right thalamus, right caudate body, right lateral glo-
bus pallidus, exhibited significantly higher brain acti-
vation than other brain areas during ACUP. During
SHAM, healthy participants showed significant brain
activation in the right putamen, right precentral gyrus,
right inferior, frontal gyrus, right putamen and right
thalamus.
In patients with PD, the right superior frontal gyrus,
left middle frontal gyrus, left and right inferior frontal
gyrus, left and right precentral gyrus and left and right
putamen exhibited significantly higher brain activation
than other brain areas during ACUP. During SHAM,
the left superior frontal gyrus, left middle frontal
gyrus, left and right inferior frontal gyrus, left and
right precentral gyrus and right putamen exhibited
significantly higher brain activation than other brain
areas in patients with PD (Figure 1, Table 1 and Additional
file 4: Table S2).
Comparison of brain activation between healthy
participants and patients with PD during ACUP
Healthy participants showed significantly higher brain
activation in the right middle frontal gyrus, right hippo-
campus, left and right caudate body, left and right caud-
ate tail, left thalamus, right putamen, right insula and
right cingulate gyrus than patients with PD.
Moreover, patients with PD showed significantly higher
brain activation in the left inferior frontal gyrus, left pre-
central gyrus, left precuneus, left postcentral gyrus, left su-
perior temporal gyrus, left middle temporal gyrus, left
inferior temporal gyrus, left insula, left claustrum and left
fusiform gyrus than healthy participants (Additional file 5:
Figure S3 and Table 2).
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Volume of the prefrontal cortex and precentral gyrus
activated by ACUP and SHAM
Volume of the prefrontal cortex and precentral gyrus in-
duced by ACUP were significantly bigger than that by
SHAM (Figure 2).
Common areas activated on both patients with PD and
healthy participants during ACUP and SHAM
The volume of common areas which were activated by
ACUP was significantly larger than that by SHAM
(Figure 3).
Discussion
In this fMRI study, brain activation due to acupuncture
in a group of healthy participants and in a group of pa-
tients with PD was investigated. We hypothesized that
ACUP on GB 34 has an effect on brain areas that are
known to show dysfunction due to nigral dopamine de-
pletion. Moreover, our second hypothesis was that a dif-
ference in brain activity would be identified in patients
with PD when compared with healthy participants.
In line with our first hypothesis, our neuroimaging re-
sults show that ACUP on GB 34, among other areas, in-
deed activated the prefrontal cortex and the precentral
gyrus in patients with PD, but not in healthy participants
(Figure 1 and Table 1). Moreover, the putamen was acti-
vated in both groups. The prefrontal cortex [37], precen-
tral gyrus [38], and putamen [38] are all known to be
affected by PD. In a simple finger-tapping task, acupunc-
ture at GB34 showed a significant improvement of
motor function on the affected hand before and after
ACUP on GB34 (13.6%; P < 0.05) [47], and led to in-
creased activation of the putamen and the primary
motor cortex in patients with PD [47]. The precentral
gyrus is a part of the primary motor cortex that contains
large neurons, which connect to the muscle [53]. The
putamen is interconnected with so many other struc-
tures, it works in conjunction with them to control
many types of motor skills such as motor learning, per-
formance [54], preparation [55] and movement sequences
[56]. Local impairments in the putamen may affect the
whole corticostriatal network [57]. In particular, brain
activation of the left putamen was only shown follow-
ing ACUP in patients with PD. It seems that acupunc-
ture, which is known to have an effect on the dopamine
system [58], affects these dysfunctional corticostriatal
networks.
Figure 1 Brain activation among healthy participants and patients with PD during acupuncture stimulation and sham stimulation
(one-sample t-test; with corrected cluster level P < 0.05). The bar is the t value.
Table 1 PD related brain activation induced by ACUP and
SHAM in healthy participants and patients with PD
SHAM
Healthy
ACUP
Healthy
SHAM PD ACUP PD
L R L R L R L R
Prefrontal cortex o o o o o
Precentral gyrus o o o o o
Thalamus o o o
Globus pallidus o
Caudate o
Putamen o o o o o
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Our results following ACUP also exhibited significant
brain activation in the right superior and inferior frontal
gyrus and left middle and inferior frontal gyrus among
the prefrontal cortex (Additional file 5: Table S2). Con-
sistent with previous studies, our results also confirmed
that ACUP activated areas related to corticostriatal net-
works, which are impaired in patients with PD.
In addition, the thalamus [39] and the globus pallidus
[40] were, according to our first hypothesis, also acti-
vated after ACUP on GB 34; however, this was only the
case in healthy participants. More specifically, in healthy
participants, it was found that almost all brain activation
occurred in the basal ganglia. The right putamen, left
and right thalamus, right caudate, right insula, and right
lateral globus pallidus exhibited significantly higher brain
activation than other brain areas during ACUP (Table 1).
Consistent with previous studies, differences of brain ac-
tivity between ACUP and SHAM in healthy participants
were observed. ACUP on left GB34 in healthy participants
activated the right putamen, caudate body, claustrum,
thalamus, cerebellum, as well as the left caudate body,
thalamus, and cerebellum, all which are related to motor
Table 2 Comparisons of neural responses between patients with PD and healthy participants during acupuncture
stimulation
Healthy > Patients with PD Healthy < Patients with PD
Cerebral area Coordinates anatomical
location
Statistical values Coordinates anatomical
location
Statistical values
Brain region L/R Brodmann area x y z t value x y z t value
Frontal lobe
Middle frontal gyrus Right 6 21 5 48 3.19 - - - -
Inferior frontal gyrus Left 45/47 - - - - −32 29 −1 4.47
Precentral gyrus Left 4/6 - - - - −28 −29 57 5.36
Parietal lobe
Precuneus Left 7 - - - - −26 −59 36 5.37
Postcentral gyrus Left 2/3/40 - - - - −46 −19 43 5.36
Temporal lobe
Hippocampus Right 32 −35 0 4.63 - - - -
Superior temporal gyrus Left 22/38/41 - - - - −51 −22 3 4.69
Middle temporal gyrus Left 37 - - - - −40 −60 5 4.39
Inferior temporal gyrus Left 19 - - - - −44 −52 2 3.99
Sub-lobar
Caudate body Right 15 −29 27 5.04 - - - -
Caudate tail Right 25 −35 21 3.96 - - - -
Putamen Right 25 3 16 3.98 - - - -
Insula Right 13 30 −15 27 3.41 - - - -
Caudate body Left −16 −23 27 4.11 - - - -
Caudate tail Left −18 −30 26 3.92 - - - -
Thalamus Left 1 −19 4 3.88 - - - -
Insula Left 13 - - - - −45 −5 5 4.81
Claustrum Left - - - - −31 19 0 4.17
Limbic lobe
Cingulate gyrus Right 23/24/31/32 23 −13 39 4.33 - - - -
Occipital lobe
Precuneus Left 31 - - - - −27 −71 21 4.34
Fusiform gyrus Left 19 - - - - −21 −66 −8 3.99
Cluster size 9920 18776
The table describes the location of the peak voxel and the corresponding brain regions and Brodmann areas comprised by the cluster. Results are reported if
cluster level corrected P < 0.05. The voxel size is 2.4 × 2.4 × 4.5 mm. “Healthy participants > Patients with PD” indicates more activated neural responses of healthy
participants compared to patients with PD. “Healthy participants < Patients with PD” indicates more activated neural responses of patients with PD compared to
healthy participants (two-sample t test; with corrected cluster level P < 0.05).
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function [59], whereas very few areas were activated when
SHAM was given [60]. Through these results, we con-
firmed that our experimental methods were clear and re-
sulted in our acceptance of the results. Based on the
results of healthy participants, we could find abnormal re-
sponses to stimulations in patients with PD.
As can be seen in Figure 1, in patients with PD, re-
gions of the brain activated after ACUP were different
with those after ACUP in healthy participants. Patients with
PD have dysfunction due to nigral dopamine depletion,
which may cause abnormal activation of the basal ganglia
compared with healthy participants [61-63]. Previous studies
have shown that compared with healthy participants, in-
creased fMRI signals were found in patients with PD during
motor tasks [63], ankle movement [64] and motor responses
[61], because they are likely to participate in the same puta-
tive attempt by the dopamine-denervated brain to recruit
parallel motor circuits to overcome the functional deficit of
the striatocortical motor loops. In our results, areas activated
in SHAM, including the paracentral lobule, superior frontal
Figure 2 Volume of areas activated by ACUP and SHAM. ‘A’ is for the precentral gyrus and ‘B’ is for the prefrontal cortex (paired-t test; *P < 0.05).
Figure 3 Common areas activated on both patients with PD and healthy participants during ACUP and SHAM. Left graph shows the
significant difference in common region volume activated by ACUP and SHAM. *P < 0.005.
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gyrus, inferior parietal lobule, superior parietal lobule, precu-
neus, middle temporal gyrus, inferior temporal gyrus, claus-
trum, insula and middle occipital gyrus, all disappeared
following ACUP. Instead of that, the left putamen was acti-
vated following acupuncture. It is possible that these areas
became activated to compensate for nigral dopamine deple-
tion in patients with PD and that ACUP may calm these
areas down to normal activity levels, as observed in healthy
participants.
With respect to our second hypothesis, a comparison
of brain activation results (Table 2) showed that ACUP
indeed evoked different brain activation in patients with
PD than in healthy participants. Interestingly, patients
with PD showed significantly higher brain activation in
the prefrontal cortex and precentral gyrus, especially in
the left hemisphere. Because acupuncture in our study
was conducted on the right leg, brain activation can be
expected to be greater in opposite brain areas. Moreover,
note that the prefrontal cortex and precentral gyrus are
known to be affected by PD [37,38]. Our neuroimaging
results seem to indicate that the effects of acupuncture
treatment are visible in these areas in patients with PD,
but not in healthy participants.
However, it remains unclear why the effect of acu-
puncture on GB 34 is visible in the prefrontal cortex and
precentral gyrus and not in the thalamus, globus palli-
dus, and caudate, which are areas that are also known to
be affected by PD [38,39,41]. In previous studies [63,65],
it was found that the prefrontal cortex and precentral
gyrus were impaired in patients with PD when conduct-
ing motor tasks and that these areas are related to motor
function. Because GB 34 was reported to be involved in
motor function treatment [47], the treatment effect in
the prefrontal cortex and precentral gyrus that was
found in patients with PD in our study is in line with
previous findings in these motor task studies [63,65].
The prefrontal cortex is considered to induce actions in
accordance with internal goals [66] and has been shown
to be involved in composing and conducting voluntary
behavior [67], whereas the precentral gyrus is associated
with planning and execution of movement [68-70].
The volume activated by ACUP in the precentral gyrus
and prefrontal cortex was bigger than that by SHAM
(Figure 2). This is thought that even if the precentral
gyrus and prefrontal cortex were activated also by SHAM,
ACUP acted on the brain stronger than SHAM. Moreover,
the volume of common areas which were activated by
ACUP on both patients with PD and healthy participants
was significantly larger than that by SHAM (Figure 3).
This result suggests that the level of ACUP activation in
the brains of PD patients is similar to that of healthy par-
ticipants compared against SHAM.
The limitation of this study is that we should have ob-
served motor improvement instead of just referring to
existing literature. Moreover, the patients’ mean disease
duration of our participants was 2.67 years, which is a
relatively benign state of PD, so the results were slightly
differing from previous research and might only apply to
relatively patients with early PD.
Conclusions
Therefore, the neuroimaging results of our study suggest
that in future acupuncture research; the prefrontal cor-
tex as well as the precentral gyrus should be treated for
symptoms of Parkinson’s disease and that GB 34 seems
to be a suitable acupoint. Moreover, acupuncture evoked
different brain activations in patients with Parkinson’s
disease than in healthy participants in our study, stres-
sing the importance of conducting acupuncture studies
on both healthy participants as well as patients within
the same study, in order to detect acupuncture efficacy.
Additional files
Additional file 1: Table S1. Demographic characteristics among
patients with PD and healthy participants.
Additional file 2: Figure S1. Acupuncture and sham stimulations
during fMRI scanning were performed at GB 34 on the right leg
according to the WHO Standard Acupuncture Point Locations.
Additional file 3: Figure S2. The fMRI scanning paradigm. The
scanning experiment started with the SHAM condition with a duration of
5 minutes. Then, structural images were acquired, lasting more than 15
minutes. After structural imaging, the ACUP condition with a duration of
5 minutes followed.
Additional file 4: Table S2. Neural responses among healthy
participants and patients with PD during acupuncture stimulations (one-sample
t test; with corrected cluster level P < 0.05).
Additional file 5: Figure S3. Comparison of brain activation between
patients with PD and healthy participants during acupuncture
stimulation. “Healthy participants > Patients with PD” indicates more
activated brain activation of healthy participants compared with patients
with PD. “Healthy participants < Patients with PD” indicates more
activated brain activation of patients with PD compared with healthy
participants (two-sample t-test; with corrected cluster level P < 0.05). The
bar is the t value.
Competing interests
The authors declare that they have no competing interest.
Authors’ contributions
SY, IHC, SL designed the experiment; SL organized the experiment; SY, GHJ
performed the experiments; SY analyzed the data; SY, MN, PB, BR, SK wrote
the manuscript; All authors discussed the data and the analysis methods and
contributed to the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was supported by the Ministry of Health and Welfare, Republic of
Korea (Oriental Medicine R&D Project, B080049) and by the National
Research Foundation of Korea (NRF) grant funded by the Korea government
(No. 2007–0054931, NRF-2014R1A1A1004100).
Author details
1Research Group of Pain and Neuroscience, WHO Collaborating Centre,
East–west Medical Research Institute, Kyung Hee University, Seoul,
Republic of Korea. 2College of Oriental Medicine, Kyung Hee University,
Seoul, Republic of Korea. 3Free University of Brussels, Brussels, Belgium.
Yeo et al. BMC Complementary and Alternative Medicine 2014, 14:336 Page 7 of 9
http://www.biomedcentral.com/1472-6882/14/336
4Donders Institute for Brain, Cognition and Behaviour, Radboud University
Nijmegen, Nijmegen, The Netherlands. 5College of Medicine, Kyung Hee
University, Seoul, Republic of Korea. 6Athinoula A. Martinos Center for
Biomedical Imaging, Department of Radiology, Massachusetts General
Hospital, Harvard Medical School, Boston, USA.
Received: 12 September 2013 Accepted: 23 June 2014
Published: 15 September 2014
References
1. Pecci C, Rivas MJ, Moretti CM, Raina G, Ramirez CZ, Diaz S, Uribe Roca C,
Micheli FE: Use of complementary and alternative therapies in outpatients
with Parkinson’s disease in Argentina. Mov Disord 2010, 25(13):2094–2098.
2. Denman M: ACP Journal Club. Review: evidence for the effectiveness of
acupuncture for pain is mixed. Ann Intern Med 2011, 155(4):JC2–JC6.
3. Fang JL, Krings T, Weidemann J, Meister IG, Thron A: Functional MRI in
healthy subjects during acupuncture: different effects of needle rotation
in real and false acupoints. Neuroradiology 2004, 46(5):359–362.
4. Lee MS, Shin BC, Kong JC, Ernst E: Effectiveness of acupuncture for
Parkinson’s disease: a systematic review. Mov Disord 2008, 23(11):1505–1515.
5. Liu B, Chen J, Wang J, Liu X, Duan X, Shang X, Long Y, Chen Z, Li X, Huang Y,
He Y: Altered small-world efficiency of brain functional networks in
acupuncture at ST36: a functional MRI study. PLoS One 2012, 7(6):e39342.
6. Yeo S, Choi YG, Hong YM, Lim S: Neuroprotective changes of thalamic
degeneration-related gene expression by acupuncture in an MPTP
mouse model of parkinsonism: microarray analysis. Gene 2013, 515(2):329–338.
7. Campbell A: Point specificity of acupuncture in the light of recent clinical
and imaging studies. Acupunct Med 2006, 24(3):118–122.
8. Chae Y, Park HJ, Hahm DH, Hong M, Ha E, Park HK, Lee H: fMRI review on
brain responses to acupuncture: the limitations and possibilities in
traditional Korean acupuncture. Neurol Res 2007, 29(Suppl 1):S42–S48.
9. Dhond RP, Kettner N, Napadow V: Neuroimaging acupuncture effects in
the human brain. J Altern Complement Med 2007, 13(6):603–616.
10. Kaptchuk TJ: Acupuncture: theory, efficacy, and practice. Ann Intern Med
2002, 136(5):374–383.
11. Lewith GT, White PJ, Kaptchuk TJ: Developing a research strategy for
acupuncture. Clin J Pain 2006, 22(7):632–638.
12. Chae Y, Lee H, Kim H, Sohn H, Park JH, Park HJ: The neural substrates of
verum acupuncture compared to non-penetrating placebo needle: an
fMRI study. Neurosci Lett 2009, 450(2):80–84.
13. Kong J, Kaptchuk TJ, Polich G, Kirsch I, Vangel M, Zyloney C, Rosen B, Gollub R:
Expectancy and treatment interactions: a dissociation between
acupuncture analgesia and expectancy evoked placebo analgesia.
Neuroimage 2009, 45(3):940–949.
14. Wu MT, Sheen JM, Chuang KH, Yang P, Chin SL, Tsai CY, Chen CJ, Liao JR,
Lai PH, Chu KA, Pan HB, Yang CF: Neuronal specificity of acupuncture
response: a fMRI study with electroacupuncture. Neuroimage 2002,
16(4):1028–1037.
15. Wu Y, Jin Z, Li K, Lu ZL, Wong V, Han TL, Zheng H, Caspi O, Liu G, Zeng YW,
Zou LP: Functional magnetic resonance imaging activation of the
brain in children: real acupoint versus sham acupoint. J Child Neurol
2010, 25(7):849–855.
16. Chau AC, Fai Cheung RT, Jiang X, Au-Yeung PK, Li LS: An fMRI study showing
the effect of acupuncture in chronic stage stroke patients with aphasia.
J Acupunct Meridian Stud 2010, 3(1):53–57.
17. Li G, Jack CR Jr, Yang ES: An fMRI study of somatosensory-implicated
acupuncture points in stable somatosensory stroke patients. J Magn
Reson Imaging 2006, 24(5):1018–1024.
18. Zhou Y, Jin J: Effect of acupuncture given at the HT 7, ST 36, ST 40 and
KI 3 acupoints on various parts of the brains of Alzheimer’ s disease
patients. Acupunct Electrother Res 2008, 33(1–2):9–17.
19. Shulman LM, Wen X, Weiner WJ, Bateman D, Minagar A, Duncan R, Konefal J:
Acupuncture therapy for the symptoms of Parkinson’s disease. Mov Disord
2002, 17(4):799–802.
20. Wu T, Long X, Zang Y, Wang L, Hallett M, Li K, Chan P: Regional
homogeneity changes in patients with Parkinson’s disease. Hum Brain
Mapp 2009, 30(5):1502–1510.
21. DeLong MR: Primate models of movement disorders of basal ganglia
origin. Trends Neurosci 1990, 13(7):281–285.
22. Albin RL, Young AB, Penney JB: The functional anatomy of basal ganglia
disorders. Trends Neurosci 1989, 12(10):366–375.
23. Davie CA: A review of Parkinson’s disease. Br Med Bull 2008, 86:109–127.
24. Chung V, Liu L, Bian Z, Zhao Z, Leuk Fong W, Kum WF, Gao J, Li M: Efficacy
and safety of herbal medicines for idiopathic Parkinson’s disease: a
systematic review. Mov Disord 2006, 21(10):1709–1715.
25. Kim SR, Lee TY, Kim MS, Lee MC, Chung SJ: Use of complementary and
alternative medicine by Korean patients with Parkinson’s disease. Clin
Neurol Neurosurg 2009, 111(2):156–160.
26. Klein PJ, Rivers L: Taiji for individuals with Parkinson disease and their
support partners: a program evaluation. J Neurol Phys Ther 2006, 30(1):22–27.
27. Tan LC, Lau PN, Jamora RD, Chan ES: Use of complementary therapies in
patients with Parkinson’s disease in Singapore. Mov Disord 2006, 21(1):86–89.
28. Rajendran PR, Thompson RE, Reich SG: The use of alternative therapies by
patients with Parkinson’s disease. Neurology 2001, 57(5):790–794.
29. Liang XB, Liu XY, Li FQ, Luo Y, Lu J, Zhang WM, Wang XM, Han JS: Long-term
high-frequency electro-acupuncture stimulation prevents neuronal
degeneration and up-regulates BDNF mRNA in the substantia nigra
and ventral tegmental area following medial forebrain bundle axotomy.
Brain Res Mol Brain Res 2002, 108(1–2):51–59.
30. Kim SN, Doo AR, Park JY, Choo HJ, Shim I, Park JJ, Chae Y, Lee B, Lee H, Park HJ:
Combined treatment with acupuncture reduces effective dose and alleviates
adverse effect of l-dopa by normalizing Parkinson’s disease-induced
neurochemical imbalance. Brain Res 2014, 1544:33–44.
31. Wang H, Liang X, Wang X, Luo D, Jia J: Electro-acupuncture stimulation
improves spontaneous locomotor hyperactivity in MPTP intoxicated
mice. PLoS One 2013, 8(5):e64403.
32. Lam YC, Kum WF, Durairajan SS, Lu JH, Man SC, Xu M, Zhang XF, Huang XZ,
Li M: Efficacy and safety of acupuncture for idiopathic Parkinson’s
disease: a systematic review. J Altern Complement Med 2008, 14(6):663–671.
33. Zhuang X, Wang L: Acupuncture treatment of Parkinson’s disease–a
report of 29 cases. J Tradit Chin Med 2000, 20(4):265–267.
34. Yeo S, Lim S, Choe IH, Choi YG, Chung KC, Jahng GH, Kim SH: Acupuncture
stimulation on GB34 activates neural responses associated with
Parkinson’s disease. CNS Neurosci Ther 2012, 18(9):781–790.
35. Choi YG, Yeo S, Hong YM, Lim S: Neuroprotective changes of striatal
degeneration-related gene expression by acupuncture in an MPTP
mouse model of Parkinsonism: microarray analysis. Cell Mol Neurobiol
2011, 31(3):377–391.
36. Jeon S, Kim YJ, Kim ST, Moon W, Chae Y, Kang M, Chung MY, Lee H, Hong
MS, Chung JH, Joh TH, Park HJ: Proteomic analysis of the neuroprotective
mechanisms of acupuncture treatment in a Parkinson’s disease mouse
model. Proteomics 2008, 8(22):4822–4832.
37. Tinaz S, Schendan HE, Stern CE: Fronto-striatal deficit in Parkinson’s disease
during semantic event sequencing. Neurobiol Aging 2008, 29(3):397–407.
38. Yu H, Sternad D, Corcos DM, Vaillancourt DE: Role of hyperactive
cerebellum and motor cortex in Parkinson’s disease. Neuroimage 2007,
35(1):222–233.
39. Lewis MM, Slagle CG, Smith AB, Truong Y, Bai P, McKeown MJ, Mailman RB,
Belger A, Huang X: Task specific influences of Parkinson’s disease on the
striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
Neuroscience 2007, 147(1):224–235.
40. Silberstein P, Kuhn AA, Kupsch A, Trottenberg T, Krauss JK, Wohrle JC,
Mazzone P, Insola A, Di Lazzaro V, Oliviero A, Aziz T, Brown P: Patterning of
globus pallidus local field potentials differs between Parkinson’s disease
and dystonia. Brain 2003, 126(Pt 12):2597–2608.
41. van Eimeren T, Monchi O, Ballanger B, Strafella AP: Dysfunction of the
default mode network in Parkinson disease: a functional magnetic
resonance imaging study. Arch Neurol 2009, 66(7):877–883.
42. Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality.
Neurology 1967, 17(5):427–442.
43. Fahn S, Elton R, Members of the UPDRS Development Committee: Unified
Parkinson's disease rating scale. In Recent Developments in Parkinson's Disease.
Volume 2. Edited by Fahn S, Marsden CD, Calne DB, Goldstein M. Florham Park,
New Jersey: Macmillan Health Care Information; 1987:153–163. 293-304.
44. Oldfield RC: The assessment and analysis of handedness: the Edinburgh
inventory. Neuropsychologia 1971, 9(1):97–113.
45. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A,
Moher D: Revised STandards for Reporting Interventions in Clinical Trials of
Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010,
7(6):e1000261.
46. Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ,
Kim CJ, Kim YS, Chung JH: Acupuncture prevents 6-hydroxydopamine-induced
Yeo et al. BMC Complementary and Alternative Medicine 2014, 14:336 Page 8 of 9
http://www.biomedcentral.com/1472-6882/14/336
neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson’s
disease model. Exp Neurol 2003, 180(1):93–98.
47. Chae Y, Lee H, Kim H, Kim CH, Chang DI, Kim KM, Park HJ: Parsing brain
activity associated with acupuncture treatment in Parkinson’s diseases.
Mov Disord 2009, 24(12):1794–1802.
48. Dhond RP, Yeh C, Park K, Kettner N, Napadow V: Acupuncture modulates
resting state connectivity in default and sensorimotor brain networks.
Pain 2008, 136(3):407–418.
49. van den Noort M, Specht K, Rimol LM, Ersland L, Hugdahl K: A new verbal
reports fMRI dichotic listening paradigm for studies of hemispheric
asymmetry. Neuroimage 2008, 40(2):902–911.
50. Cho B, Yang J, Kim S, Yang DW, Park M, Chey J: The validity and reliability
of a Computerized Dementia Screening Test developed in Korea. J Neurol
Sci 2002, 203–204:109–114.
51. Beck AT, Steer RA: Internal consistencies of the original and revised Beck
Depression Inventory. J Clin Psychol 1984, 40(6):1365–1367.
52. Mezer A, Yovel Y, Pasternak O, Gorfine T, Assaf Y: Cluster analysis of
resting-state fMRI time series. Neuroimage 2009, 45(4):1117–1125.
53. Binkofski F, Fink GR, Geyer S, Buccino G, Gruber O, Shah NJ, Taylor JG, Seitz RJ,
Zilles K, Freund HJ: Neural activity in human primary motor cortex areas 4a
and 4p is modulated differentially by attention to action. J Neurophysiol
2002, 88(1):514–519.
54. DeLong MR, Alexander GE, Georgopoulos AP, Crutcher MD, Mitchell SJ,
Richardson RT: Role of basal ganglia in limb movements. Hum Neurobiol
1984, 2(4):235–244.
55. Alexander GE, Crutcher MD: Preparation for movement: neural
representations of intended direction in three motor areas of the
monkey. J Neurophysiol 1990, 64(1):133–150.
56. Marchand WR, Lee JN, Thatcher JW, Hsu EW, Rashkin E, Suchy Y, Chelune G,
Starr J, Barbera SS: Putamen coactivation during motor task execution.
Neuroreport 2008, 19(9):957–960.
57. Helmich RC, Derikx LC, Bakker M, Scheeringa R, Bloem BR, Toni I: Spatial
remapping of cortico-striatal connectivity in Parkinson’s disease. Cereb
Cortex 2010, 20(5):1175–1186.
58. Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, Lim S: Acupuncture
inhibits microglial activation and inflammatory events in the MPTP-induced
mouse model. Brain Res 2007, 1131(1):211–219.
59. Na BJ, Jahng GH, Park SU, Jung WS, Moon SK, Park JM, Bae HS: An fMRI
study of neuronal specificity of an acupoint: electroacupuncture
stimulation of Yanglingquan (GB34) and its sham point. Neurosci Lett
2009, 464(1):1–5.
60. Jeun SS, Kim JS, Kim BS, Park SD, Lim EC, Choi GS, Choe BY: Acupuncture
stimulation for motor cortex activities: a 3 T fMRI study. Am J Chin Med
2005, 33(4):573–578.
61. Baglio F, Blasi V, Falini A, Farina E, Mantovani F, Olivotto F, Scotti G, Nemni R,
Bozzali M: Functional brain changes in early Parkinson’s disease during
motor response and motor inhibition. Neurobiol Aging 2011, 32(1):115–124.
62. Palomar FJ, Diaz-Corrales F, Carrillo F, Fernandez-del-Olmo M, Koch G, Mir P:
Sensory perception changes induced by transcranial magnetic stimulation
over the primary somatosensory cortex in Parkinson’s disease. Mov Disord
2011, 26(11):2058–2064.
63. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L,
Berry I, Montastruc JL, Chollet F, Rascol O: Cortical motor reorganization in
akinetic patients with Parkinson’s disease: a functional MRI study. Brain
2000, 123(Pt 2):394–403.
64. Katschnig P, Schwingenschuh P, Jehna M, Svehlik M, Petrovic K, Ropele S,
Zwick EB, Ott E, Fazekas F, Schmidt R, Enzinger C: Altered functional
organization of the motor system related to ankle movements in
Parkinson’s disease: insights from functional MRI. J Neural Transm 2011,
118(5):783–793.
65. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks
DJ: Self-initiated versus externally triggered movements. I. An
investigation using measurement of regional cerebral blood flow with
PET and movement-related potentials in normal and Parkinson’s disease
subjects. Brain 1995, 118(Pt 4):913–933.
66. Miller EK, Freedman DJ, Wallis JD: The prefrontal cortex: categories,
concepts and cognition. Philos Trans R Soc Lond B Biol Sci 2002, 357
(1424):1123–1136.
67. Levy R, Volle E: The prefrontal cortex: composer and conductor of
voluntary behaviors. Rev Neurol (Paris) 2009, 165 Spec No 3:F159–F177.
68. Carpenter AF, Georgopoulos AP, Pellizzer G: Motor cortical encoding of
serial order in a context-recall task. Science 1999, 283(5408):1752–1757.
69. Crowe DA, Chafee MV, Averbeck BB, Georgopoulos AP: Participation of
primary motor cortical neurons in a distributed network during maze
solution: representation of spatial parameters and time-course comparison
with parietal area 7a. Exp Brain Res 2004, 158(1):28–34.
70. Georgopoulos AP, Lurito JT, Petrides M, Schwartz AB, Massey JT: Mental
rotation of the neuronal population vector. Science 1989, 243(4888):234–236.
doi:10.1186/1472-6882-14-336
Cite this article as: Yeo et al.: Acupuncture on GB34 activates the
precentral gyrus and prefrontal cortex in Parkinson’s disease. BMC
Complementary and Alternative Medicine 2014 14:336.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yeo et al. BMC Complementary and Alternative Medicine 2014, 14:336 Page 9 of 9
http://www.biomedcentral.com/1472-6882/14/336
